DVA - DaVita Inc.
NYSE
->
Healthcare
->
Medical Care Facilities
Denver,
United States
Type: Equity
DVA price evolution
DVA
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 1 May 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $503.25 | $430.78 | $464.63 | |
| Short term investments | $20.69 | $10.61 | $11.61 | |
| Net receivables | $2631.37 | $2723.74 | $2991.07 | $2409.53 |
| Inventory | $129 | $126.77 | $145.81 | $143.1 |
| Total current assets | $4037 | $3466.93 | $3683.75 | $3137.91 |
| Long term investments | $485.49 | $540.27 | $593.74 | |
| Property, plant & equipment | $5357.97 | $5439.79 | $5513.33 | $5574.9 |
| Goodwill & intangible assets | $7392.88 | $7431.14 | $7315.78 | |
| Total noncurrent assets | $13558.65 | $13747.18 | $13755.67 | |
| Total investments | $506.18 | $550.88 | $605.35 | |
| Total assets | $17503.74 | $17025.57 | $17430.94 | $16893.58 |
| Current liabilities | ||||
| Accounts payable | $488.24 | $493.53 | $489.88 | $514.53 |
| Deferred revenue | ||||
| Short long term debt | $942.81 | $528.99 | $517.7 | |
| Total current liabilities | $2943.99 | $2994.79 | $2583.1 | $2642.21 |
| Long term debt | $9260.33 | $10732.93 | $9000.59 | $10598.72 |
| Total noncurrent liabilities | $11605.93 | $12211.85 | $11508.01 | |
| Total debt | $11675.75 | $11841.48 | $11116.42 | |
| Total liabilities | $17117.02 | $14600.72 | $16504.94 | $14150.23 |
| Shareholders' equity | ||||
| Retained earnings | $1275.3 | $1060.61 | $837.94 | $598.29 |
| Other shareholder equity | -$162.33 | -$195.09 | -$100.11 | -$52.08 |
| Total shareholder equity | $632.9 | $926 | $1056.1 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $464.63 | $338.99 | $554.96 | $501.79 |
| Short term investments | $11.61 | $77.69 | $22.31 | $20.1 |
| Net receivables | $2409.53 | $2550.65 | $2384.9 | $2368.66 |
| Inventory | $143.1 | $109.12 | $107.43 | $111.63 |
| Total current assets | $3137.91 | $3155.29 | $3167.72 | $3148.72 |
| Long term investments | $593.74 | $275.44 | $288.39 | $289.68 |
| Property, plant & equipment | $5574.9 | $5922.64 | $6304.76 | $6384.91 |
| Goodwill & intangible assets | $7315.78 | $7259.3 | $7223.93 | $7085.69 |
| Total noncurrent assets | $13755.67 | $13772.96 | $13953.76 | $13839.79 |
| Total investments | $605.35 | $353.13 | $310.7 | $309.79 |
| Total assets | $16893.58 | $16928.25 | $17121.49 | $16988.52 |
| Current liabilities | ||||
| Accounts payable | $514.53 | $479.78 | $402.05 | $434.25 |
| Deferred revenue | ||||
| Short long term debt | $517.7 | $626.8 | $573.39 | $538.04 |
| Total current liabilities | $2642.21 | $2619.75 | $2398.53 | $2476.14 |
| Long term debt | $10598.72 | $8692.62 | $11401.86 | $10655.93 |
| Total noncurrent liabilities | $11508.01 | $12083.7 | $12351.98 | $11615.59 |
| Total debt | $11116.42 | $11822.49 | $11975.25 | $11193.97 |
| Total liabilities | $14150.23 | $16215.93 | $14750.51 | $14091.74 |
| Shareholders' equity | ||||
| Retained earnings | $598.29 | $174.49 | $354.34 | $852.54 |
| Other shareholder equity | -$52.08 | -$69.19 | -$139.25 | -$66.15 |
| Total shareholder equity | $1056.1 | $712.33 | $755.51 | $1383.57 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3263.59 | $3186.72 | $3070.55 | $3145.75 |
| Cost of revenue | $2142.3 | $2078.98 | $2138.37 | |
| Gross Profit | $1111.71 | $1044.42 | $991.58 | $1007.38 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $367.85 | $362.48 | $401.47 | |
| Total operating expenses | $580.55 | $543.51 | $514.42 | $622.83 |
| Operating income | $500.92 | $477.16 | $384.55 | |
| Income from continuing operations | ||||
| EBIT | $392.11 | $404.87 | $305.35 | |
| Income tax expense | $77.67 | $71.69 | $65.81 | $58.49 |
| Interest expense | -$130.87 | $97.75 | $99.42 | $96.19 |
| Net income | ||||
| Net income | $214.69 | $222.68 | $239.65 | $150.66 |
| Income (for common shares) | $222.68 | $239.65 | $150.66 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $12140.15 | $11609.89 | $11618.8 | $11550.6 |
| Cost of revenue | $8319.72 | $8209.55 | $7972.41 | $7988.61 |
| Gross Profit | $3820.43 | $3400.34 | $3646.38 | $3561.99 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1473.98 | $1355.2 | $1195.34 | $1247.58 |
| Total operating expenses | $2245.51 | $2087.8 | $1875.95 | $1894.27 |
| Operating income | $1574.92 | $1312.54 | $1770.43 | $1667.72 |
| Income from continuing operations | ||||
| EBIT | $1310.2 | $1115.51 | $1570.44 | $1391.68 |
| Income tax expense | $220.12 | $198.09 | $306.73 | $313.93 |
| Interest expense | $398.55 | $357.02 | $285.25 | $304.11 |
| Net income | ||||
| Net income | $691.53 | $560.4 | $978.45 | $773.64 |
| Income (for common shares) | $691.53 | $560.4 | $978.45 | $773.64 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $222.68 | $239.65 | $150.66 | |
| Operating activities | ||||
| Depreciation | $175.66 | $187.08 | $195.28 | |
| Business acquisitions & disposals | -$46.88 | -$98.12 | -$12.7 | |
| Stock-based compensation | $24.29 | $24.54 | $30.06 | |
| Total cash flows from operations | $798.85 | -$134.84 | $485.2 | |
| Investing activities | ||||
| Capital expenditures | -$124.72 | -$121.02 | -$158.97 | |
| Investments | $9.85 | $3.93 | $3.38 | |
| Total cash flows from investing | -$523.46 | -$161.76 | -$215.21 | -$168.3 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$361.44 | -$337.45 | -$279.18 | |
| Net borrowings | -$121.32 | $735.71 | -$28.7 | |
| Total cash flows from financing | -$251.83 | -$563.29 | $319.32 | -$403.25 |
| Effect of exchange rate | -$5.11 | -$1.33 | -$3.13 | $5.85 |
| Change in cash and equivalents | $694.01 | $72.47 | -$33.85 | -$80.49 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $691.53 | $560.4 | $978.45 | $773.64 |
| Operating activities | ||||
| Depreciation | $745.44 | $732.6 | $680.62 | $630.43 |
| Business acquisitions & disposals | $4.22 | $60.27 | -$125.59 | -$131.87 |
| Stock-based compensation | $112.38 | $95.43 | $102.21 | $91.46 |
| Total cash flows from operations | $2059.03 | $1564.57 | $1930.88 | $1979.03 |
| Investing activities | ||||
| Capital expenditures | -$567.99 | -$603.43 | -$641.47 | -$674.54 |
| Investments | -$208.03 | -$86.41 | -$16.94 | -$18.96 |
| Total cash flows from investing | -$771.8 | -$630.35 | -$784.73 | -$825.37 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$320.33 | -$839.6 | -$1598.63 | -$1459.42 |
| Net borrowings | -$552.62 | -$11.28 | $754.25 | -$63.53 |
| Total cash flows from financing | -$1170.49 | -$1121.13 | -$1082.97 | -$1846.78 |
| Effect of exchange rate | $8.91 | -$29.07 | -$10.01 | -$13.81 |
| Change in cash and equivalents | $125.64 | -$215.97 | $53.17 | -$706.93 |
News
Fundamentals
| Market cap | $13.56B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 82.62M |
| Revenue | $12.67B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $827.68M |
| Revenue Q/Q | 4.56% |
| Revenue Y/Y | 6.34% |
| P/E ratio | 16.39 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.07 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $10.02 |
|---|---|
| ROA | 4.81% |
| ROE | N/A |
| Debt/Equity | 13.40 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.37 |
| Quick ratio | 1.33 |